Theravet SA ALVET.PA
Last Updated: Jan 27, 12:00 AM·XPAR
ALVET.PA Shariah Compliance
Screening Methodology: AAOIFI
As of July 2026, Theravet SA is classified as halal.
HALAL
Report Source: 2023 Annual Report
Theravet SA. Stock Analysis ALVET.PA
France Health Care Nano Cap Report: EGEIRO Pharma is a veterinary biotech company, which specializes in the development and production of treatments for osteoarticular diseases in cats, dogs, and horses. The company is headquartered in Charleroi, Hainaut. The company went IPO on 2021-06-17. The firm develops treatments to improve the standard of life of pets suffering from orthopedic, osteoarticular, joint and bone diseases. The company focuses on the indications and applications of osteoarthritis, ligament, tendon injuries and bone surgery in cats and dogs as well as horses. The company develops new treatments and veterinary products specifically adapted to pets from formulation to production through preclinical, clinical and regulatory evaluation. The company is situated in the places like Belgium and abroad (France, Switzerland, United Kingdom and United States).
Read More Theravet SA (ALVET.PA) Chart
Key Statistics of Theravet SA (ALVET.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€0.08Volume
2040.00P/E Ratio (TTM)
-52 Week Range
Market Cap
290.00KAvg. Volume
18.47KDividend Yield
-Financial Metrics & Statements of Theravet SA (ALVET.PA)
Super Investors Invested in Theravet SA (ALVET.PA)
FAQ's for Theravet SA (ALVET.PA)
- As of July 2026, Theravet SA ALVET.PA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Theravet SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Theravet SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Theravet SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Theravet SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Theravet SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.